A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.

Bax, Bridget E

A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency. [electronic resource] - European journal of haematology Oct 2007 - 338-48 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

0902-4441

10.1111/j.1600-0609.2007.00927.x doi


Adenosine Deaminase--administration & dosage
Adenosylhomocysteinase--immunology
Adult
Antigens, CD20--blood
Autoantibodies--blood
Deoxyadenine Nucleotides--immunology
Enzymes, Immobilized--administration & dosage
Erythrocytes--enzymology
Female
Forced Expiratory Flow Rates--drug effects
Humans
Immunoglobulin G--blood
Lung Diseases--enzymology
Lymphocyte Count
Polyethylene Glycols--administration & dosage
Severe Combined Immunodeficiency--drug therapy
Time Factors